Isotretinoin and the controversy of psychiatric adverse effects

Jamison E. Strahan, Sharon Raimer

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Isotretinoin is a synthetic oral retinoid that has great efficacy against severe, recalcitrant, nodulocystic acne. Since its introduction to the market, it has been associated with a variety of adverse psychiatric effects, including depression, psychosis, mood swings, violent behavior, suicide, and suicide attempts. A MEDLINE review was performed to compile all case reports, case series, adverse drug event reportings, and prospective and retrospective studies relating psychiatric adverse events to isotretinoin. In addition, literature linking a biological mechanism for psychiatric adverse events to retinoid signaling pathways was also reviewed. Although a variety of anecdotal and epidemiologic studies are available, the overall lack of concrete scientific data limits any conclusion that can be drawn about a causal relationship between istotretinoin and psychiatric adverse events. Several lines of evidence link retinoid signaling to theorized psychiatric pathogenesis, but are limited in their applicability to adult neurophysiology.

Original languageEnglish (US)
Pages (from-to)789-799
Number of pages11
JournalInternational Journal of Dermatology
Volume45
Issue number7
DOIs
StatePublished - Jul 2006

Fingerprint

Isotretinoin
Psychiatry
Retinoids
Suicide
Biological Psychiatry
Neurophysiology
Acne Vulgaris
Drug-Related Side Effects and Adverse Reactions
MEDLINE
Psychotic Disorders
Epidemiologic Studies
Retrospective Studies
Prospective Studies
Depression

ASJC Scopus subject areas

  • Dermatology

Cite this

Isotretinoin and the controversy of psychiatric adverse effects. / Strahan, Jamison E.; Raimer, Sharon.

In: International Journal of Dermatology, Vol. 45, No. 7, 07.2006, p. 789-799.

Research output: Contribution to journalArticle

Strahan, Jamison E. ; Raimer, Sharon. / Isotretinoin and the controversy of psychiatric adverse effects. In: International Journal of Dermatology. 2006 ; Vol. 45, No. 7. pp. 789-799.
@article{c78c23abc7884c599a909cd852065c19,
title = "Isotretinoin and the controversy of psychiatric adverse effects",
abstract = "Isotretinoin is a synthetic oral retinoid that has great efficacy against severe, recalcitrant, nodulocystic acne. Since its introduction to the market, it has been associated with a variety of adverse psychiatric effects, including depression, psychosis, mood swings, violent behavior, suicide, and suicide attempts. A MEDLINE review was performed to compile all case reports, case series, adverse drug event reportings, and prospective and retrospective studies relating psychiatric adverse events to isotretinoin. In addition, literature linking a biological mechanism for psychiatric adverse events to retinoid signaling pathways was also reviewed. Although a variety of anecdotal and epidemiologic studies are available, the overall lack of concrete scientific data limits any conclusion that can be drawn about a causal relationship between istotretinoin and psychiatric adverse events. Several lines of evidence link retinoid signaling to theorized psychiatric pathogenesis, but are limited in their applicability to adult neurophysiology.",
author = "Strahan, {Jamison E.} and Sharon Raimer",
year = "2006",
month = "7",
doi = "10.1111/j.1365-4632.2006.02660.x",
language = "English (US)",
volume = "45",
pages = "789--799",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Isotretinoin and the controversy of psychiatric adverse effects

AU - Strahan, Jamison E.

AU - Raimer, Sharon

PY - 2006/7

Y1 - 2006/7

N2 - Isotretinoin is a synthetic oral retinoid that has great efficacy against severe, recalcitrant, nodulocystic acne. Since its introduction to the market, it has been associated with a variety of adverse psychiatric effects, including depression, psychosis, mood swings, violent behavior, suicide, and suicide attempts. A MEDLINE review was performed to compile all case reports, case series, adverse drug event reportings, and prospective and retrospective studies relating psychiatric adverse events to isotretinoin. In addition, literature linking a biological mechanism for psychiatric adverse events to retinoid signaling pathways was also reviewed. Although a variety of anecdotal and epidemiologic studies are available, the overall lack of concrete scientific data limits any conclusion that can be drawn about a causal relationship between istotretinoin and psychiatric adverse events. Several lines of evidence link retinoid signaling to theorized psychiatric pathogenesis, but are limited in their applicability to adult neurophysiology.

AB - Isotretinoin is a synthetic oral retinoid that has great efficacy against severe, recalcitrant, nodulocystic acne. Since its introduction to the market, it has been associated with a variety of adverse psychiatric effects, including depression, psychosis, mood swings, violent behavior, suicide, and suicide attempts. A MEDLINE review was performed to compile all case reports, case series, adverse drug event reportings, and prospective and retrospective studies relating psychiatric adverse events to isotretinoin. In addition, literature linking a biological mechanism for psychiatric adverse events to retinoid signaling pathways was also reviewed. Although a variety of anecdotal and epidemiologic studies are available, the overall lack of concrete scientific data limits any conclusion that can be drawn about a causal relationship between istotretinoin and psychiatric adverse events. Several lines of evidence link retinoid signaling to theorized psychiatric pathogenesis, but are limited in their applicability to adult neurophysiology.

UR - http://www.scopus.com/inward/record.url?scp=33745625649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745625649&partnerID=8YFLogxK

U2 - 10.1111/j.1365-4632.2006.02660.x

DO - 10.1111/j.1365-4632.2006.02660.x

M3 - Article

VL - 45

SP - 789

EP - 799

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

IS - 7

ER -